Detalhe da pesquisa
1.
miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts.
Cell
; 140(5): 652-65, 2010 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-20211135
2.
Somatic variants in epigenetic modifiers can predict failure of response to imatinib but not to second-generation tyrosine kinase inhibitors.
Haematologica
; 104(12): 2400-2409, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31073075
3.
BCR-ABL1 mediated miR-150 downregulation through MYC contributed to myeloid differentiation block and drug resistance in chronic myeloid leukemia.
Haematologica
; 103(12): 2016-2025, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30049824
4.
Precision immunotherapy, mutational landscape, and emerging tools to optimize clinical outcomes in patients with classical myeloproliferative neoplasms.
Hematol Oncol
; 36(5): 740-748, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30074634
5.
Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells.
Blood
; 123(18): 2826-37, 2014 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24668492
6.
Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status.
PLoS Genet
; 9(3): e1003311, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23505378
7.
Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignancies.
Blood
; 122(11): 1923-34, 2013 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-23926298
8.
Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias.
Blood
; 122(17): 3034-44, 2013 Oct 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-23970380
9.
Lenalidomide-mediated enhanced translation of C/EBPα-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia.
Blood
; 121(1): 159-69, 2013 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-23100311
10.
Rac guanosine triphosphatases represent integrating molecular therapeutic targets for BCR-ABL-induced myeloproliferative disease.
Cancer Cell
; 12(5): 467-78, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17996650
11.
miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eµ-miR-155 transgenic mouse model.
Proc Natl Acad Sci U S A
; 109(49): 20047-52, 2012 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23169640
12.
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response.
Proc Natl Acad Sci U S A
; 109(31): E2110-6, 2012 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-22753494
13.
Regulation of acute graft-versus-host disease by microRNA-155.
Blood
; 119(20): 4786-97, 2012 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-22408260
14.
Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia.
Blood
; 119(25): 6025-31, 2012 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-22566605
15.
Mutated beta-catenin evades a microRNA-dependent regulatory loop.
Proc Natl Acad Sci U S A
; 108(12): 4840-5, 2011 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-21383185
16.
Protein phosphatase 2A: a target for anticancer therapy.
Lancet Oncol
; 14(6): e229-38, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23639323
17.
The PP2A inhibitor SET regulates natural killer cell IFN-gamma production.
J Exp Med
; 204(10): 2397-405, 2007 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-17875674
18.
Twisting IL-1 signaling to kill CML stem cells.
Blood
; 128(23): 2592-2593, 2016 12 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27932325
19.
The PP2A inhibitor SET regulates granzyme B expression in human natural killer cells.
Blood
; 117(8): 2378-84, 2011 Feb 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-21156847
20.
Sphingosine kinase-1 and sphingosine 1-phosphate receptor 2 mediate Bcr-Abl1 stability and drug resistance by modulation of protein phosphatase 2A.
Blood
; 117(22): 5941-52, 2011 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-21527515